Focus on Lymphoma
One of the more important breakthroughs in recent years has been the development of DNA microarrays. These are tests of gene patterns in a tumor’s DNA that may help spot abnormal genes in the tumor.
Emerging Therapies in Non-Hodgkin Lymphoma
Research into the causes, prevention, and treatment of non-Hodgkin lymphoma is being done in many medical centers throughout the world.
What Happens After Treatment for Non-Hodgkin Lymphoma?
Completing treatment can be both stressful and exciting. You will be relieved to finish treatment, yet it is hard not to worry about cancer coming back. This is a very common concern among those who have had cancer.
Drug Treatment for Cutaneous T-cell Lymphoma Approved
The U.S. Food and Drug Administration has approved Gloucester Pharmaceuticals’ Istodax® (romidepsin), an injectable medication, for treatment of people with a rare form of cancer known as cutaneous T-cell lymphoma.
